Sartorius Stedim Biotech S.A.

ENXTPA:DIM Rapporto sulle azioni

Cap. di mercato: €18.7b

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Sartorius Stedim Biotech Crescita futura

Future criteri di controllo 4/6

Sartorius Stedim Biotech prevede che gli utili e i ricavi cresceranno rispettivamente di 29% e 10% all'anno. Si prevede che l'EPS crescerà di 27.7% all'anno. Si prevede che il ritorno sul capitale proprio sarà di 13.3% in 3 anni.

Informazioni chiave

30.3%

Tasso di crescita degli utili

29.1%

Tasso di crescita dell'EPS

Life Sciences crescita degli utili25.9%
Tasso di crescita dei ricavi10.3%
Rendimento futuro del capitale proprio13.3%
Copertura analitica

Good

Ultimo aggiornamento20 Sep 2024

Aggiornamenti recenti sulla crescita futura

Sartorius Stedim Biotech S.A. Just Missed Earnings - But Analysts Have Updated Their Models

Jul 21
Sartorius Stedim Biotech S.A. Just Missed Earnings - But Analysts Have Updated Their Models

Sartorius Stedim Biotech S.A. Just Missed EPS By 26%: Here's What Analysts Think Will Happen Next

Apr 21
Sartorius Stedim Biotech S.A. Just Missed EPS By 26%: Here's What Analysts Think Will Happen Next

Recent updates

Does Sartorius Stedim Biotech (EPA:DIM) Have A Healthy Balance Sheet?

Aug 11
Does Sartorius Stedim Biotech (EPA:DIM) Have A Healthy Balance Sheet?

Sartorius Stedim Biotech S.A. Just Missed Earnings - But Analysts Have Updated Their Models

Jul 21
Sartorius Stedim Biotech S.A. Just Missed Earnings - But Analysts Have Updated Their Models

Estimating The Fair Value Of Sartorius Stedim Biotech S.A. (EPA:DIM)

Jul 12
Estimating The Fair Value Of Sartorius Stedim Biotech S.A. (EPA:DIM)

Sartorius Stedim Biotech (EPA:DIM) Has A Somewhat Strained Balance Sheet

May 13
Sartorius Stedim Biotech (EPA:DIM) Has A Somewhat Strained Balance Sheet

Sartorius Stedim Biotech S.A. Just Missed EPS By 26%: Here's What Analysts Think Will Happen Next

Apr 21
Sartorius Stedim Biotech S.A. Just Missed EPS By 26%: Here's What Analysts Think Will Happen Next

With A 26% Price Drop For Sartorius Stedim Biotech S.A. (EPA:DIM) You'll Still Get What You Pay For

Apr 20
With A 26% Price Drop For Sartorius Stedim Biotech S.A. (EPA:DIM) You'll Still Get What You Pay For

Weak Statutory Earnings May Not Tell The Whole Story For Sartorius Stedim Biotech (EPA:DIM)

Feb 19
Weak Statutory Earnings May Not Tell The Whole Story For Sartorius Stedim Biotech (EPA:DIM)

Sartorius Stedim Biotech S.A.'s (EPA:DIM) Popularity With Investors Is Clear

Dec 22
Sartorius Stedim Biotech S.A.'s (EPA:DIM) Popularity With Investors Is Clear

Is Sartorius Stedim Biotech (EPA:DIM) Using Too Much Debt?

Dec 01
Is Sartorius Stedim Biotech (EPA:DIM) Using Too Much Debt?

Are Sartorius Stedim Biotech S.A. (EPA:DIM) Investors Paying Above The Intrinsic Value?

Nov 10
Are Sartorius Stedim Biotech S.A. (EPA:DIM) Investors Paying Above The Intrinsic Value?

Does Sartorius Stedim Biotech (EPA:DIM) Have A Healthy Balance Sheet?

Aug 23
Does Sartorius Stedim Biotech (EPA:DIM) Have A Healthy Balance Sheet?

Sartorius Stedim Biotech (EPA:DIM) Seems To Use Debt Quite Sensibly

May 25
Sartorius Stedim Biotech (EPA:DIM) Seems To Use Debt Quite Sensibly

Here's Why We Think Sartorius Stedim Biotech (EPA:DIM) Is Well Worth Watching

May 09
Here's Why We Think Sartorius Stedim Biotech (EPA:DIM) Is Well Worth Watching

Are Sartorius Stedim Biotech S.A. (EPA:DIM) Investors Paying Above The Intrinsic Value?

Apr 23
Are Sartorius Stedim Biotech S.A. (EPA:DIM) Investors Paying Above The Intrinsic Value?

Here's Why Sartorius Stedim Biotech (EPA:DIM) Can Manage Its Debt Responsibly

Feb 07
Here's Why Sartorius Stedim Biotech (EPA:DIM) Can Manage Its Debt Responsibly

Does Sartorius Stedim Biotech (EPA:DIM) Deserve A Spot On Your Watchlist?

Jan 20
Does Sartorius Stedim Biotech (EPA:DIM) Deserve A Spot On Your Watchlist?

Sartorius Stedim Biotech (EPA:DIM) Has A Pretty Healthy Balance Sheet

Nov 09
Sartorius Stedim Biotech (EPA:DIM) Has A Pretty Healthy Balance Sheet

Here's Why We Think Sartorius Stedim Biotech (EPA:DIM) Might Deserve Your Attention Today

Oct 20
Here's Why We Think Sartorius Stedim Biotech (EPA:DIM) Might Deserve Your Attention Today

Estimating The Fair Value Of Sartorius Stedim Biotech S.A. (EPA:DIM)

Oct 03
Estimating The Fair Value Of Sartorius Stedim Biotech S.A. (EPA:DIM)

We Think Sartorius Stedim Biotech (EPA:DIM) Can Stay On Top Of Its Debt

Jul 26
We Think Sartorius Stedim Biotech (EPA:DIM) Can Stay On Top Of Its Debt

Do Sartorius Stedim Biotech's (EPA:DIM) Earnings Warrant Your Attention?

Jul 09
Do Sartorius Stedim Biotech's (EPA:DIM) Earnings Warrant Your Attention?

Is Sartorius Stedim Biotech S.A. (EPA:DIM) Expensive For A Reason? A Look At Its Intrinsic Value

Jun 21
Is Sartorius Stedim Biotech S.A. (EPA:DIM) Expensive For A Reason? A Look At Its Intrinsic Value

Sartorius Stedim Biotech (EPA:DIM) Could Easily Take On More Debt

Apr 21
Sartorius Stedim Biotech (EPA:DIM) Could Easily Take On More Debt

Here's Why I Think Sartorius Stedim Biotech (EPA:DIM) Is An Interesting Stock

Apr 03
Here's Why I Think Sartorius Stedim Biotech (EPA:DIM) Is An Interesting Stock

We Like Sartorius Stedim Biotech's (EPA:DIM) Earnings For More Than Just Statutory Profit

Feb 24
We Like Sartorius Stedim Biotech's (EPA:DIM) Earnings For More Than Just Statutory Profit

Does Sartorius Stedim Biotech (EPA:DIM) Have A Healthy Balance Sheet?

Dec 04
Does Sartorius Stedim Biotech (EPA:DIM) Have A Healthy Balance Sheet?

Sartorius Stedim Biotech (EPA:DIM) Could Easily Take On More Debt

Aug 21
Sartorius Stedim Biotech (EPA:DIM) Could Easily Take On More Debt

Previsioni di crescita degli utili e dei ricavi

ENXTPA:DIM - Stime future degli analisti e dati finanziari passati (EUR Millions )
DataRicaviGuadagniFlusso di cassa liberoLiquidità dell'operazioneAvg. Numero di analisti
12/31/20263,40045442584111
12/31/20253,04334534575211
12/31/20242,78421230366811
6/30/20242,747170305706N/A
3/31/20242,716255169636N/A
12/31/20232,776310273746N/A
9/30/20232,959460113625N/A
6/30/20233,170635162675N/A
3/31/20233,356717137606N/A
12/31/20223,493876182612N/A
9/30/20223,381681125552N/A
6/30/20223,259625193584N/A
3/31/20223,094559322661N/A
12/31/20212,887414378702N/A
9/30/20212,639523355623N/A
6/30/20212,393469367590N/A
3/31/20212,143398310506N/A
12/31/20201,910336258417N/A
9/30/20201,743299299414N/A
6/30/20201,600255243365N/A
3/31/20201,520254216345N/A
12/31/20191,441235174310N/A
9/30/20191,393247142291N/A
6/30/20191,33623821261N/A
3/31/20191,27422388270N/A
12/31/20181,21220851227N/A
9/30/20181,17218557226N/A
6/30/20181,121173147225N/A
3/31/20181,093162N/A196N/A
12/31/20171,081161N/A175N/A
9/30/20171,073151N/A165N/A
6/30/20171,089157N/A169N/A
3/31/20171,075157N/A146N/A
12/31/20161,052154N/A157N/A
9/30/20161,009145N/A146N/A
6/30/2016971142N/A129N/A
3/31/2016926136N/A155N/A
12/31/2015884118N/A143N/A
9/30/2015850111N/A150N/A
6/30/201578189N/A128N/A
3/31/201573476N/A113N/A
12/31/201468472N/A111N/A
9/30/201464671N/A93N/A
6/30/201462067N/A110N/A
3/31/201460468N/A97N/A
12/31/201358866N/A90N/A

Previsioni di crescita futura degli analisti

Guadagni vs tasso di risparmio: La crescita prevista degli utili di DIM ( 29% all'anno) è superiore al tasso di risparmio ( 1.2% ).

Guadagni vs Mercato: Si prevede che gli utili di DIM ( 29% all'anno) cresceranno più rapidamente del mercato French ( 12.3% all'anno).

Guadagni ad alta crescita: Si prevede che gli utili di DIM cresceranno in modo significativo nei prossimi 3 anni.

Ricavi vs Mercato: Si prevede che il fatturato di DIM ( 10% all'anno) crescerà più rapidamente del mercato French ( 5.8% all'anno).

Ricavi ad alta crescita: Si prevede che il fatturato di DIM ( 10% all'anno) crescerà più lentamente di 20% all'anno.

Previsioni di crescita dell'utile per azione

Rendimento futuro del capitale proprio

ROE futuro: Si prevede che il Return on Equity di DIM sarà basso tra 3 anni ( 13.3 %).

Scoprire le aziende in crescita

7D

1Y

7D

1Y

7D

1Y